Immunic Inc. (IMUX) Reports FY21 EPS of ($3.93)

Immunic Inc. (NASDAQ: IMUX) reported FY21 EPS of ($3.93). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Wedbush Starts Immunic Inc. (IMUX) at Outperform
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print
• Taylor Devices (TAYD) Misses Q4 EPS by 31c